SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-19-058464
Filing Date
2019-12-02
Accepted
2019-12-02 14:10:28
Documents
1
Period of Report
2019-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2477
  Complete submission text file 0001209191-19-058464.txt   4120
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Issuer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21250 HAWTHORNE BLVD., SUITE 800 TORRANCE CA 90503
Business Address
ZEN Wei Peu (Reporting) CIK: 0001746204 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-35527 | Film No.: 191262906